Hong Ding

4.0k total citations
80 papers, 2.3k citations indexed

About

Hong Ding is a scholar working on Molecular Biology, Hematology and Cell Biology. According to data from OpenAlex, Hong Ding has authored 80 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 9 papers in Hematology and 7 papers in Cell Biology. Recurrent topics in Hong Ding's work include Protein Degradation and Inhibitors (18 papers), Epigenetics and DNA Methylation (16 papers) and Cancer-related gene regulation (12 papers). Hong Ding is often cited by papers focused on Protein Degradation and Inhibitors (18 papers), Epigenetics and DNA Methylation (16 papers) and Cancer-related gene regulation (12 papers). Hong Ding collaborates with scholars based in China, United States and United Kingdom. Hong Ding's co-authors include Hualiang Jiang, Cheng Luo, Chris R. Triggle, Saul H. Rosenberg, Steven W. Elmore, Stephen W. Fesik, Alexander R. Shoemaker, Mingyue Zheng, Kaixian Chen and Weichun He and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Hong Ding

76 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong Ding China 26 1.7k 349 311 166 154 80 2.3k
Shingo Dan Japan 26 1.4k 0.8× 493 1.4× 278 0.9× 98 0.6× 294 1.9× 95 2.3k
Tina S. Homayouni Canada 4 999 0.6× 430 1.2× 209 0.7× 126 0.8× 223 1.4× 4 1.9k
Tomohiro Kawamoto Japan 24 1.1k 0.7× 301 0.9× 473 1.5× 161 1.0× 179 1.2× 61 1.9k
Hariprasad Vankayalapati United States 21 1.5k 0.9× 257 0.7× 280 0.9× 75 0.5× 180 1.2× 61 2.2k
Wen Luo China 23 973 0.6× 217 0.6× 334 1.1× 232 1.4× 91 0.6× 80 1.7k
Hiroyuki Miyachi Japan 28 1.1k 0.6× 340 1.0× 665 2.1× 91 0.5× 171 1.1× 93 2.1k
Bing Xiong China 26 1.5k 0.9× 243 0.7× 566 1.8× 291 1.8× 73 0.5× 143 2.3k
Jon Read United Kingdom 25 1.3k 0.8× 199 0.6× 369 1.2× 227 1.4× 236 1.5× 40 2.1k
Emmanuelle J. Meuillet United States 30 1.7k 1.0× 334 1.0× 331 1.1× 73 0.4× 244 1.6× 65 2.4k

Countries citing papers authored by Hong Ding

Since Specialization
Citations

This map shows the geographic impact of Hong Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Ding more than expected).

Fields of papers citing papers by Hong Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Ding. The network helps show where Hong Ding may publish in the future.

Co-authorship network of co-authors of Hong Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Ding. A scholar is included among the top collaborators of Hong Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Ding. Hong Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaoxia, et al.. (2025). Research on the impact of land use and meteorological factors on the spatial distribution characteristics of PM2.5 concentration. Atmospheric Pollution Research. 16(5). 102462–102462.
2.
Chen, Yanfang, Haonan Zhou, Jiamin Yu, et al.. (2025). A patent review of BRD4 inhibitors (2020–present). Expert Opinion on Therapeutic Patents. 35(4). 371–386. 3 indexed citations
3.
Sarkar, Aparajita, Isra Marei, Hong Ding, et al.. (2024). Repurposing Metformin for the Treatment of Atrial Fibrillation: Current Insights. Vascular Health and Risk Management. Volume 20. 255–288. 6 indexed citations
4.
Gao, Jing, et al.. (2023). A patent review of PRMT5 inhibitors to treat cancer (2018 - present). Expert Opinion on Therapeutic Patents. 33(4). 265–292. 11 indexed citations
5.
Jiang, Hao, Qiao Guo, Huimin Zhang, et al.. (2023). A RhoA structure with switch II flipped outward revealed the conformational dynamics of switch II region. Journal of Structural Biology. 215(2). 107942–107942. 3 indexed citations
6.
Gan, Yulin, Yu Zhang, Sicong Jiang, et al.. (2022). Fractional-unit-cell-doped spinel/perovskite oxide interfaces with switchable carrier conduction. Applied Physics Letters. 121(11). 2 indexed citations
7.
Yan, Xiaoyan, et al.. (2021). Effects of heat-sensitive moxibustion combined with naprapathy and warming needle moxibustion combined with naprapathy in patients with periarthritis of shoulder.. American Journal of Translational Research. 13(7). 7804–7811. 5 indexed citations
8.
Ding, Hong, Yuan‐Qing Li, Wen Xu, et al.. (2021). Design, synthesis and biological evaluation of a novel spiro oxazolidinedione as potent p300/CBP HAT inhibitor for the treatment of ovarian cancer. Bioorganic & Medicinal Chemistry. 52. 116512–116512. 14 indexed citations
9.
Min, Wenjian, Rukang Zhang, Yuan‐Qing Li, et al.. (2020). Lead discovery, chemical optimization, and biological evaluation studies of novel histone methyltransferase SET7 small-molecule inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(9). 127061–127061. 14 indexed citations
10.
Han, Jie, Yucheng Tian, Liang Yu, et al.. (2020). Discovery of novel USP8 inhibitors via Ubiquitin-Rho-110 fluorometric assay based high throughput screening. Bioorganic Chemistry. 101. 103962–103962. 9 indexed citations
11.
Chen, Yu, Pan Xu, Hao Jiang, et al.. (2020). Design, synthesis, and biological evaluation of tetrahydroquinolin derivatives as potent inhibitors of CBP bromodomain. Bioorganic Chemistry. 101. 103991–103991. 12 indexed citations
13.
Chen, Wei, Hao Zhang, Zhifeng Chen, et al.. (2018). Development and evaluation of a novel series of Nitroxoline-derived BET inhibitors with antitumor activity in renal cell carcinoma. Oncogenesis. 7(11). 83–83. 11 indexed citations
14.
Lu, Tian, Junchi Hu, Wenchao Lu, et al.. (2018). Identification of small molecule inhibitors targeting the SMARCA2 bromodomain from a high-throughput screening assay. Acta Pharmacologica Sinica. 39(9). 1544–1552. 23 indexed citations
15.
Xiong, Huan, Jie Han, Jun Wang, et al.. (2018). Discovery of 1,8-acridinedione derivatives as novel GCN5 inhibitors via high throughput screening. European Journal of Medicinal Chemistry. 151. 740–751. 30 indexed citations
16.
Gao, Zhen, Dan Zhao, Lunfeng Zhang, et al.. (2017). PI-273, a Substrate-Competitive, Specific Small-Molecule Inhibitor of PI4KIIα, Inhibits the Growth of Breast Cancer Cells. Cancer Research. 77(22). 6253–6266. 36 indexed citations
17.
Jiang, Hao, Jing Xing, Chen Wang, et al.. (2017). Discovery of novel BET inhibitors by drug repurposing of nitroxoline and its analogues. Organic & Biomolecular Chemistry. 15(44). 9352–9361. 29 indexed citations
18.
Yao, Xingang, Ping Li, Jing Chen, et al.. (2013). Natural product vindoline stimulates insulin secretion and efficiently ameliorates glucose homeostasis in diabetic murine models. Journal of Ethnopharmacology. 150(1). 285–297. 46 indexed citations
19.
Ding, Hong, Dong Zhou, Sha Hao, et al.. (2012). Sonic Hedgehog Signaling Mediates Epithelial–Mesenchymal Communication and Promotes Renal Fibrosis. Journal of the American Society of Nephrology. 23(5). 801–813. 169 indexed citations
20.
Shao, Yong, et al.. (2007). Synthesis and structure–activity relationships study of novel anti-tumor carbamate anhydrovinblastine analogues. Bioorganic & Medicinal Chemistry. 15(15). 5061–5075. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026